Literature DB >> 16516200

Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.

Patrícia Sampaio Tavares Veras1, Marcus Welby-Borges, Cláudia Dias de Santana, Jorge Nihei, Fabiola Cardillo, Luiz Antônio Rodrigues de Freitas.   

Abstract

CBA/J mice are resistant to Leishmania major and susceptible to Leishmania amazonensis. Early events determine infection outcome. Until now, PIV (in vitro priming) immune response to L. amazonensis has not been assessed. Herein, we have shown that compared to L. major, L. amazonensis induced higher parasite burden associated to similar IL-4, IFN-gamma, and TNF-alpha mRNA expressions and IFN-gamma and IL-10 levels. Although similar amounts of IL-10 were detected, the frequency of intracellular IL-10 positive B cells was enhanced in spleen cells stimulated with anti-CD3/anti-CD28, or anti-CD3/anti-CD28 and L. amazonensis, compared to L. major-stimulation. Interestingly, IL-10- producing B cells were reduced in response to anti-CD3/anti-CD28 stimulation combined with L. major compared to the other groups. L. amazonensis may favor T regulatory cell development, since 40% of all the CD4+CD25+ were CD25(high) cells. These data suggest that in PIV, susceptibility to L. amazonensis is not related to Th cell polarization, but to the presence and activity of regulatory T and B cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516200     DOI: 10.1016/j.exppara.2006.01.008

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 2.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

3.  T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

Authors:  Tobias Schwarz; Katharina A Remer; Wiebke Nahrendorf; Anita Masic; Lisa Siewe; Werner Müller; Axel Roers; Heidrun Moll
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

4.  Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL).

Authors:  Alireza Badirzadeh; Mehdi Najm; Andrew Hemphill; Maryam Alipour; Hamid Hasanpour; Leila Masoori; Poorya Karimi
Journal:  PLoS One       Date:  2022-09-08       Impact factor: 3.752

5.  17-AAG kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages.

Authors:  Antonio Luis de Oliveira Almeida Petersen; Carlos Eduardo Sampaio Guedes; Carolina Leite Versoza; José Geraldo Bomfim Lima; Luiz Antônio Rodrigues de Freitas; Valéria Matos Borges; Patrícia Sampaio Tavares Veras
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

6.  An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Marie M Bockenstedt; Huijuan Li; Paola M Boggiatto; Yashdeep Phanse; Christine A Petersen; Bryan H Bellaire; Douglas E Jones
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

Review 7.  Cutaneous Leishmaniasis Vaccination: A Matter of Quality.

Authors:  Paula Mello De Luca; Amanda Beatriz Barreto Macedo
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

8.  IFN-gamma expression is up-regulated by peripheral blood mononuclear cells (PBMC) from non-exposed dogs upon Leishmania chagasi promastigote stimulation in vitro.

Authors:  Cleusa Alves Theodore Rodrigues; Luís Fábio da Silva Batista; Roberto Santos Teixeira Filho; Claire da Silva Santos; Cristiane Garboggini Pinheiro; Taís Fontoura de Almeida; Luiz Antônio Rodrigues de Freitas; Patrícia Sampaio Tavares Veras
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.